Tumor angiogenesis, from foe to friend

Science

Volumn 349, Issue 6249, 2015, Pages 694-695

  Rivera, Lee B ^a   Bergers, Gabriele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILENGITIDE; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; FIBROBLAST GROWTH FACTOR 4; GEMCITABINE; JAGGED1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; SNAKE VENOM;

CELLS AND CELL COMPONENTS; DISEASE CONTROL; DRUG; HYPOXIA; REGROWTH; TUMOR;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CELL ADHESION; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; NEOPLASM; OXYGENATION; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VASCULARIZATION; ANIMAL; CELL HYPOXIA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR RECURRENCE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL HYPOXIA; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SNAKE VENOMS;

EID: 84940181878     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aad0862     Document Type: Short Survey

References (10)

1. R. K. Jain, Cancer Cell 26, 605 (2014).
2. A. Hollebecque, C. Massard, J. C. Soria, Curr. Opin. Oncol. 24, 305 (2012).
3. G. Bergers, D. Hanahan, Nat. Rev. Cancer 8, 592 (2008).
4. R. K. Jain, Nat. Med. 7, 987 (2001).
5. H. Maes et al., Cancer Cell 26, 190 (2014).
6. P. P. Wong et al., Cancer Cell 27, 123 (2015).
7. A. R. Reynolds et al., Nat. Med. 15, 392 (2009).
8. J. M. Butler, H. Kobayashi, S. Rafii, Nat. Rev. Cancer 10, 138 (2010).
9. Z. Cao et al., Cancer Cell 25, 350 (2014).
10. B. Tavora et al., Nature 514, 112 (2014).